Nitori (NCLTY) Stock Chart & Stock Price History → Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad) Free NCLTY Stock Alerts $13.48 -0.24 (-1.75%) (As of 05/7/2024 ET) Add Compare Share Share ChartStock AnalysisChartInsider TradesStock AnalysisChartInsider Trades Nitori Stock Price Performance5 Day Performance+0.88%1 Month Performance-11.25%3 Month Performance+3.94%6 Month Performance+27.93%Year-To-Date Performance+2.69%1 Year Performance+7.19% Receive NCLTY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nitori and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceThe Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.Go here now for this breaking story. NCLTY Stock Chart for Wednesday, May, 8, 2024 NCLTY Chart by TradingView Nitori Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/06/2024$13.73$13.72-0.07%$13.98$13.4922,323 shs$15.51 billion05/03/2024$13.60$13.73+0.96%$13.98$13.4042,706 shs$15.52 billion05/02/2024$13.03$13.60+4.41%$13.86$13.2832,405 shs$15.37 billion05/01/2024$13.36$13.03-2.52%$13.19$13.0014,423 shs$14.72 billion04/30/2024$13.97$13.36-4.35%$13.87$13.3441,391 shs$15.10 billion04/29/2024$13.71$13.97+1.90%$14.15$13.6624,643 shs$15.79 billion Get the Latest News and Ratings for NCLTY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nitori and its competitors with MarketBeat's FREE daily newsletter. 04/26/2024$13.85$13.71-1.00%$14.26$13.4257,155 shs$15.49 billion04/25/2024$13.94$13.85-0.63%$14.18$13.5519,512 shs$15.65 billion04/24/2024$13.72$13.94+1.58%$14.26$13.5814,835 shs$15.75 billion04/23/2024$13.62$13.72+0.73%$14.11$13.3917,713 shs$15.51 billion04/22/2024$13.69$13.62-0.51%$13.88$13.4527,399 shs$15.39 billion04/19/2024$13.81$13.69-0.88%$14.15$13.4722,760 shs$15.47 billion04/18/2024$14.24$13.81-3.01%$14.08$13.6023,374 shs$15.61 billion04/17/2024$14.40$14.24-1.11%$14.33$13.9724,432 shs$16.09 billion04/16/2024$15.09$14.40-4.54%$14.79$14.1033,018 shs$16.27 billion04/15/2024$15.19$15.09-0.69%$15.41$14.6335,609 shs$17.05 billion04/12/2024$15.44$15.19-1.62%$15.25$14.9125,860 shs$17.17 billion04/11/2024$15.28$15.44+1.05%$15.76$15.0116,250 shs$17.45 billion04/10/2024$15.73$15.28-2.83%$15.60$15.2126,240 shs$17.27 billion04/09/2024$15.54$15.73+1.22%$16.05$15.1113,803 shs$17.77 billion04/08/2024$15.46$15.54+0.49%$16.03$15.4438,753 shs$17.56 billion04/05/2024$15.46$15.54+0.49%$15.62$15.4638,753 shs$17.56 billion04/04/2024$15.52$15.46-0.35%$15.92$15.0833,880 shs$17.47 billion04/03/2024$15.54$15.52-0.16%$15.76$14.7971,599 shs$17.53 billion04/02/2024$15.54$15.54$15.58$15.3050,613 shs$17.56 billion04/01/2024$15.15$15.54+2.57%$16.05$15.1150,613 shs$17.56 billion03/29/2024$15.15$15.15$15.55$15.04795,911 shs$17.12 billion03/28/2024$15.68$15.15-3.38%$15.55$15.04795,911 shs$17.12 billion03/27/2024$15.83$15.68-0.95%$16.05$15.36618,887 shs$17.72 billion03/26/2024$15.94$15.83-0.66%$15.99$15.60324,521 shs$17.89 billion03/25/2024$15.80$15.94+0.85%$16.31$15.812.84 million shs$18.01 billion03/22/2024$15.16$15.80+4.22%$15.90$15.55748,838 shs$17.86 billion03/21/2024$15.48$15.16-2.05%$15.70$15.1610,508 shs$17.13 billion03/20/2024$15.22$15.48+1.69%$15.48$15.1813,516 shs$17.49 billion03/19/2024$15.42$15.22-1.30%$15.36$14.9720,188 shs$17.20 billion03/18/2024$15.26$15.42+1.05%$15.95$15.0814,922 shs$17.43 billion03/15/2024$15.71$15.26-2.83%$15.36$15.1916,861 shs$17.25 billion03/14/2024$15.73$15.71-0.16%$15.75$15.5618,085 shs$17.75 billion03/13/2024$16.04$15.73-1.93%$16.22$15.5619,038 shs$17.78 billion03/12/2024$15.85$16.04+1.22%$16.12$15.8115,526 shs$18.13 billionThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read03/11/2024$15.89$15.85-0.28%$16.31$15.8317,066 shs$17.91 billion03/08/2024$15.93$15.89-0.25%$16.12$15.7917,177 shs$17.96 billion03/07/2024$15.79$15.93+0.89%$16.32$15.3910,665 shs$18.00 billion03/06/2024$15.04$15.79+4.99%$16.30$15.5414,743 shs$17.84 billion03/05/2024$14.77$15.04+1.83%$15.13$14.5521,477 shs$17.00 billion03/04/2024$14.81$14.77-0.27%$14.79$14.5339,599 shs$16.69 billion03/01/2024$14.62$14.81+1.30%$14.84$14.4317,744 shs$16.74 billion02/29/2024$14.36$14.62+1.85%$14.90$14.4413,438 shs$16.52 billion02/28/2024$14.24$14.36+0.81%$14.39$14.29411,391 shs$16.22 billion02/27/2024$14.46$14.24-1.52%$14.43$13.99721,819 shs$16.09 billion02/26/2024$14.35$14.46+0.77%$14.97$14.14148,065 shs$16.34 billion02/23/2024$14.62$14.35-1.85%$14.90$14.2922,581 shs$16.22 billion02/22/2024$14.44$14.62+1.25%$14.81$14.0129,037 shs$16.52 billion02/21/2024$14.37$14.44+0.46%$14.93$14.0125,052 shs$16.32 billion02/20/2024$14.97$14.37-3.98%$14.70$14.3536,945 shs$16.24 billion02/19/2024$14.97$14.97$14.98$14.219,600 shs$16.92 billion02/16/2024$14.24$14.97+5.13%$14.98$14.219,610 shs$16.92 billion02/15/2024$13.96$14.24+2.02%$14.73$13.7839,591 shs$16.09 billion02/14/2024$13.95$13.96+0.06%$14.42$13.7833,019 shs$15.77 billion02/13/2024$14.03$13.95-0.57%$14.26$13.9142,145 shs$15.77 billion02/12/2024$14.00$14.03+0.21%$14.55$13.7515,990 shs$15.82 billion02/09/2024$13.83$14.00+1.23%$14.28$14.0018,425 shs$15.82 billion02/08/2024$13.20$13.83+4.77%$14.00$13.59183,302 shs$15.63 billion02/07/2024$13.21$13.20-0.08%$13.69$13.0259,915 shs$14.92 billion02/06/2024$13.26$13.21-0.34%$13.61$13.0430,830 shs$14.93 billion Related Companies: KRYAY Stock Chart DVDCF Stock Chart AJINY Stock Chart CIADY Stock Chart TCYMF Stock Chart ASBFY Stock Chart GLAPY Stock Chart SQNXF Stock Chart HENKY Stock Chart CAG Stock Chart Receive NCLTY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nitori and its competitors with MarketBeat's FREE daily newsletter. This page (OTC:NCLTY) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsStock-Picking AI Predicts #1 Stock of 2024AltimetryElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nitori Holdings Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.